Literature DB >> 21187291

Review article: palliative care in gynecologic oncology.

Youssef Rezk1, Patrick F Timmins, Howard S Smith.   

Abstract

Patients with advanced gynecologic malignancies have a multitude of symptoms; pain, nausea, and vomiting, constipation, anorexia, diarrhea, dyspnea, as well as symptoms resulting from intestinal obstruction, hypercalcemia, ascites, and/or ureteral obstruction. Pain is best addressed through a multimodal approach. The optimum palliative management of end-stage malignant intestinal obstruction remains controversial, with no clear guidelines governing the choice of surgical versus medical management. Patient selection for palliative surgery, therefore, should be highly individualized because only carefully selected candidates may derive real benefit from such surgeries. There remains a real need for more emphasis on palliative care education in training programs.

Entities:  

Mesh:

Year:  2010        PMID: 21187291     DOI: 10.1177/1049909110392204

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  5 in total

1.  Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population.

Authors:  Ramez N Eskander; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Robert E Bristow
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

2.  Assessment of palliative care training in gynecologic oncology: a gynecologic oncology fellow research network study.

Authors:  Ramez N Eskander; Kathryn Osann; Elizabeth Dickson; Laura L Holman; J Alejandro Rauh-Hain; Lori Spoozak; Eijean Wu; Lauren Krill; Amanda Nickles Fader; Krishnansu S Tewari
Journal:  Gynecol Oncol       Date:  2014-06-02       Impact factor: 5.482

3.  Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.

Authors:  Xin Zhang; Junling Liu; Dan Zang; Shu Wu; Aibin Liu; Jinrong Zhu; Geyan Wu; Jun Li; Lili Jiang
Journal:  Oncotarget       Date:  2015-06-20

4.  Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.

Authors:  Juanni Li; Kuan Hu; Guanghui Gong; Ding Zhu; Yixuan Wang; Hailing Liu; Xiaoying Wu
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

5.  Postpyloric decompression tube placement through a gastrostomy for malignant bowel obstruction.

Authors:  Yusuke Kurita; Tomoko Koide; Seitaro Watanabe; Tatsuya Ogawa; Yusuke Sekino; Hiroshi Iida; Takashi Nonaka; Akihiko Kusakabe; Eiji Gotoh; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  BMC Res Notes       Date:  2013-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.